Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Having plural layers
Reexamination Certificate
2008-11-12
2010-11-09
Gherbi, Suzette J (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Having plural layers
C424S423000
Reexamination Certificate
active
07828840
ABSTRACT:
This invention relates to medical devices and an angiotensin II type 2 (AT2) receptor antagonist compound, the medical device being adapted to release the AT2receptor antagonist compound within a body of a patient. This invention also relates to medical devices and methods of treatment of disease, such as aneurysms and aortic dissection. Medical devices may include coated stents, grafts, stent grafts, balloons and catheters.
REFERENCES:
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4168267 (1979-09-01), Petrillo, Jr.
patent: 4316906 (1982-02-01), Ondetti et al.
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4410520 (1983-10-01), Watthey
patent: 4432971 (1984-02-01), Karanewsky et al.
patent: 4452790 (1984-06-01), Karanewsky et al.
patent: 4464317 (1984-08-01), Thies et al.
patent: 4473575 (1984-09-01), Watthey
patent: 4508729 (1985-04-01), Vincent et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4530840 (1985-07-01), Tice et al.
patent: 4542025 (1985-09-01), Tice et al.
patent: 4587256 (1986-05-01), Hasler et al.
patent: 4622244 (1986-11-01), Lapka et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4739762 (1988-04-01), Palmaz
patent: 4780401 (1988-10-01), Heusser et al.
patent: 4845079 (1989-07-01), Luly et al.
patent: 4885292 (1989-12-01), Ryono et al.
patent: 4894437 (1990-01-01), TenBrink
patent: 4897268 (1990-01-01), Tice et al.
patent: 4943449 (1990-07-01), Aishima et al.
patent: 4980283 (1990-12-01), Huang et al.
patent: 5034512 (1991-07-01), Hudspeth et al.
patent: 5036053 (1991-07-01), Himmelsbach et al.
patent: 5036054 (1991-07-01), Kaltenbronn et al.
patent: 5045553 (1991-09-01), Ueda et al.
patent: 5055466 (1991-10-01), Weller, III et al.
patent: 5063207 (1991-11-01), Doherty et al.
patent: 5063208 (1991-11-01), Rosenberg et al.
patent: 5064965 (1991-11-01), Ocain et al.
patent: 5066643 (1991-11-01), Abeles et al.
patent: 5071837 (1991-12-01), Doherty et al.
patent: 5075451 (1991-12-01), Ocain et al.
patent: 5087634 (1992-02-01), Reitz et al.
patent: 5089471 (1992-02-01), Hanson et al.
patent: 5091205 (1992-02-01), Fan
patent: 5095119 (1992-03-01), Ocain et al.
patent: 5098924 (1992-03-01), Poss
patent: 5104869 (1992-04-01), Albright et al.
patent: 5106835 (1992-04-01), Albright et al.
patent: 5114937 (1992-05-01), Hamby et al.
patent: 5116835 (1992-05-01), Ruger et al.
patent: 5133732 (1992-07-01), Wiktor
patent: 5138069 (1992-08-01), Carini et al.
patent: 5169395 (1992-12-01), Narciso, Jr.
patent: 5256687 (1993-10-01), Becker et al.
patent: 5264581 (1993-11-01), Carini
patent: 5292331 (1994-03-01), Boneau
patent: 5298018 (1994-03-01), Narcisco, Jr.
patent: 5338740 (1994-08-01), Carpino et al.
patent: 5385894 (1995-01-01), deLaszlo et al.
patent: 5421955 (1995-06-01), Lau et al.
patent: 5441959 (1995-08-01), Chakravarty et al.
patent: 5545651 (1996-08-01), Duncia et al.
patent: 5556780 (1996-09-01), Dzau et al.
patent: 5589499 (1996-12-01), Weth
patent: 5608075 (1997-03-01), Campbell, Jr. et al.
patent: 5627158 (1997-05-01), Cho-Chung
patent: 5693762 (1997-12-01), Queen et al.
patent: 5709653 (1998-01-01), Leone
patent: 5728068 (1998-03-01), Leone et al.
patent: 5734033 (1998-03-01), Reed
patent: 5789415 (1998-08-01), Carpino et al.
patent: 5797868 (1998-08-01), Leone
patent: 5834449 (1998-11-01), Thompson et al.
patent: 5873904 (1999-02-01), Ragheb et al.
patent: 5889020 (1999-03-01), Huxley et al.
patent: 5958884 (1999-09-01), Kifor et al.
patent: 6001881 (1999-12-01), Weichert et al.
patent: 6004989 (1999-12-01), Naka et al.
patent: 6090127 (2000-07-01), Globerman
patent: 6129705 (2000-10-01), Grantz
patent: 6143022 (2000-11-01), Shull et al.
patent: 6206931 (2001-03-01), Cook et al.
patent: 6355055 (2002-03-01), Waksman et al.
patent: 6372228 (2002-04-01), Gregory
patent: 6444646 (2002-09-01), Rodgers et al.
patent: 6451050 (2002-09-01), Rudakov et al.
patent: 6641811 (2003-11-01), Suthanthiran et al.
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2002/0168393 (2002-11-01), Sugimoto
patent: 2003/0083339 (2003-05-01), Tamura
patent: 2004/0073190 (2004-04-01), Deem
patent: 2004/0176832 (2004-09-01), Harley
patent: 2005/0266043 (2005-12-01), Tseng
patent: 2005/0278021 (2005-12-01), Bates
patent: 2006/0004441 (2006-01-01), Tijsma et al.
patent: 2006/0088572 (2006-04-01), Tijsma et al.
patent: 2006/0135422 (2006-06-01), Moskowitz
patent: 2006/0223741 (2006-10-01), Smith
patent: 2007/0207186 (2007-09-01), Scanlon et al.
patent: 0 503 162 (1998-04-01), None
patent: 465368 (1998-05-01), None
patent: 1 258 258 (2002-11-01), None
patent: 2103614 (1983-02-01), None
patent: WO 98/53761 (1998-12-01), None
patent: WO 2006/066361 (2006-06-01), None
patent: WO 2006/107336 (2006-10-01), None
Sambrook et al.,Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Press, Table of Contents, (1989).
Sandhu, J., “Protein Engineering of Antibodies,”Crit. Rev. Biotech., 12(5/6):437-462 (1992).
Singer, I., et al., “Optimal Humanization of 1B4, an Anti-CD18 Murine Monoclonal Antibody, Is Achieved by Correct Choice of Human V-Region Framework Sequences,”J. lmmun., 150(7):2844-2857 (1993).
Sudhir, P.,Methods in Molecular Biology, vol. 51, Antibody Engineering Protocols, Humana Press, Inc., Table of Contents (1995).
Timmermans, P., et al., “Angiotensin II Receptors and Angiotensin II Receptor Antagonists,”Pharmacol Rev, 25(2):205-251 (1993).
Vincent, J.M., et al., “Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles,”Stroke, 36:2691-2695 (2005).
Wang, Z., et al., “Immunolocalization of Subtype 2 Angiotensin II (AT2) Receptor Protein in Rat,”Hypertension, 32(I):78-83 (1998).
Whitebread, S., et al., “Preliminary Biochemical Characterization of Two Angiotensin II Receptor Subtypes,”Biochemical and Biophysical Research Communications, 163(1):284-291 (1989).
Wiest S., et al., “Characterization of Distinct Angiotensin II Binding Sites in Rat Adrenal Gland and Bovine Cerebellum Using Selective Nonpeptide Antagonists,”J Cardiovasc Pharmacol, 17(2):177-184 (1991).
Yiu, A., et al., “Ammunohistochemical Localization of Type-II (AT2) Angiotensin Receptors with a Polyclonal Antibody Against a Peptide from the C-Terminal Tail,”Regul Pept., 70(1):15-21 (1997).
Kelley, R., “Engineering Therapeutic Antibodies,”Protein Engineering: Principles and Practice, Cleland et al. (eds.), Chapter 15; pp. 399-434, John Wiley & Sons, Inc. (1996).
Kim, W. and Kang, K., “Recent Developments of Cathepsin Inhibitors and Their Selectivity,”Expert Opin. Ther. Patents, 12(3):419-432 (2002).
Köhler, G. and Milstein, C., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,”Nature, 256:495-497 (Aug. 1975).
LeNoble et al., “Angiotensin-II induced angiogenesis is not mediated through AT1, receptor,”The FASEB Journal, 6(4):A937 (1992).
Li, J., et al., “Effects of AT1, and AT2Angiotensin Receptor Antagonists in Angiotensin II-Infused Rats,”Hypertension, 31:487-492 (1998).
Muller, C., et al., “AT2-Antagonist Sensitive Potentiation of Angiotensin II-Induced Vasoconstrictions by Blockade of Nitric Oxide Synthesis in Rate Renal Vasculature,”British J. of Pharmacology, 122:1495-1501 (1997).
Murata, K., et al., “Collagen Types in Various Layers of the Human Aorta and Their Changes with the Atherosclerotic Process,”Atherosclerosis, 60(3):251-262 (1986).
Nagashima, H., et al., “Angiotensin II Type 2 Receptor Mediates Vascular Smooth Muscle Cell Apoptosis in Cystic Medial Degeneration Associated with Marfan's Syndrome,”Circulation, 104[suppl I]:l-282-l-287 (Sep. 2001).
Nagashima, H., et al., “An Angiotensin-Converting Enzyme Inhibitor, Not an Angiotensin II Type-1 Receptor Blocker, Prevents β-aminopropionitrile Monofumarate-Induced Aortic Dissection in Rats,”J. of Vascular
Biggs David Paul
Grewe David D.
Ragheb Anthony O.
Ruane Patrick H.
Brinks Hofer Gilson & Lione
Cook Incorporated
Gherbi Suzette J
Med Institute Inc.
LandOfFree
Medical devices and methods for local delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical devices and methods for local delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical devices and methods for local delivery of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4250920